226 results on '"Rheumatoid factor -- Reports -- Forecasts and trends"'
Search Results
2. Autoinjectors Strategic Business Report 2023-2030: Rapid Shift from Self-Injectors to Autoinjectors for Easy and Safe Administration of Drugs Drives Demand
3. Rheumatoid Arthritis Market Analysis 2032: Epidemiology, Market Size and Share, FDA Approval, Clinical Trials and Companies by DelveInsight
4. Research and Markets Releases Report: Global Rheumatoid Arthritis Drugs Market
5. Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
6. Injection Pen Market Size Projected to Grow at a 7.2% CAGR until 2031, Reaching a Valuation of USD 73.7 billion | Exclusive Report by Transparency Market Research, Inc
7. Insights on the Rheumatoid Arthritis Therapeutics Global Market to 2027 - US Market is Estimated at $6.9 Billion - ResearchAndMarkets.com
8. Autoimmune Diseases Diagnostics Global Market to Surpass 6 Billion Mark by 2028 | DelveInsight
9. C Reactive Protein Testing Market Trends, Forecast and Competitive Analysis to 2030
10. Global Tofacitinib Market Research Report 2023
11. Global Tofacitinib Market Research Report 2023
12. Research and Markets Adds Report: Wrist Replacement Market
13. Autoimmune Disease Diagnostics Market Surges at 3.8% CAGR from 2019 to 2027 Fueled by Heightened Public Awareness: TMR Report
14. Autoimmune Disease Diagnostics Market Surges at 3.8% CAGR from 2019 to 2027 Fueled by Heightened Public Awareness: TMR Report
15. Autoimmune Disease Diagnostics Market Surges at 3.8% CAGR from 2019 to 2027 Fueled by Heightened Public Awareness: TMR Report
16. Global Rheumatoid Arthritis Drugs Market Aims for $49.86 Billion by 2030: Addressing a Growing Autoimmune Challenge
17. Advancing Autoimmune Disease Diagnostics Market: Surging Towards $9.84 Billion by 2030 with 7.2% CAGR - ResearchAndMarkets.com
18. Global Rheumatoid Arthritis Drugs Market 2023: Players Include Abbvie, Roche Holding, Novartis and Johnson & Johnson
19. Interleukin-6 (IL-6) Inhibitors Market is Estimated to be Worth US$ 93.3 Billion & constantly rise at a CAGR of 10.9% by forecast 2033 end | Future Market Insights, Inc
20. Juvenile Rheumatoid Arthritis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in it
21. Cortisone Acetate Market is Projected to increase at a CAGR of around 3.3% during 2023 to 2031: Exclusive report by Growth Plus Reports
22. Global Biosimilars Market Research Report 2023: A $105+ Billion Industry by 2031 - Patent Expiration of Blockbuster Biologic Drugs Driving Rapid Growth
23. Global Biosimilars Market Research Report 2023: A $105+ Billion Industry by 2031 - Patent Expiration of Blockbuster Biologic Drugs Driving Rapid Growth
24. Adalimumab Biosimilar Market Expand Lucratively & Grow at a CAGR of 23.2% to 2031
25. Global Knee Reconstruction Device Market Size Is Anticipated to Grow Around $12.54 Billion by 2028, CAGR of Nearly 4.10% | Medical Devices Industry Analysis
26. Global Knee Reconstruction Device Market Size Is Anticipated to Grow Around $12.54 Billion by 2028, CAGR of Nearly 4.10% | Medical Devices Industry Analysis
27. Global Adalimumab Market Research Report 2022
28. Antinuclear Antibody Test Market is expected to generate a revenue of USD 4.71 Billion by 2030, Globally, at 12.05% CAGR: Verified Market Research(r)
29. Insights on the Hip Replacement Global Market to 2028 - Industry Trends, Growth, Impact of Inflation, Opportunities and Company Analysis
30. Iran Anti-Rheumatic Drug Market Analysis Report 2022: A $2+ Billion Market by 2027 Featuring GlaxoSmithKline, F. Hoffmann-La Roche, & Novartis - ResearchAndMarkets.com
31. Iran Anti-Rheumatic Drug Market Analysis Report 2022: A $2+ Billion Market by 2027 Featuring GlaxoSmithKline, F. Hoffmann-La Roche, & Novartis
32. Rheumatoid Arthritis Market is Expected to Grow at a Minimal CAGR of 1.9% During the Study Period (2019-2032), Estimates DelveInsight
33. Antinuclear Antibody Testing Market Predicted to Gather $4,999.40 Million and Grow at 14.97% CAGR in the 2022-2031 Analysis Timeframe [300-Pages] | Explained by Research Dive
34. Rheumatoid Arthritis Market is Expected to Showcase Significant Growth in the 7MM at a Minimal CAGR of 1.9% During the Study Period (2019-2032), Predicts DelveInsight
35. Rheumatoid Arthritis Market is Expected to Showcase Significant Growth in the 7MM at a Minimal CAGR of 1.9% During the Study Period (2019-2032), Predicts DelveInsight
36. Insights on the Rheumatoid Arthritis Therapeutics Global Market to 2027 - US Market is Estimated at $6.9 Billion
37. Insights on the Rheumatoid Arthritis Therapeutics Global Market to 2027 - US Market is Estimated at $6.9 Billion - ResearchAndMarkets.com
38. Sales of the Pulse Electromagnetic Field (PEMF) Therapy Devices Market in 2021 had reached at level of US$ 416.6 Mn and is projected to reach a revenue of US$ 1 Bn at a CAGR of 8.6% | FMI
39. Rheumatoid Arthritis Global Market to Reach $33.3 Billion by 2030 at a CAGR of 4.5%
40. Rheumatoid Arthritis Global Market to Reach $33.3 Billion by 2030 at a CAGR of 4.5%
41. The Global Knee Reconstruction Devices Market to Accelerate Substantially at a Paltry CAGR of 4.52% by 2027 | DelveInsight
42. Canes and Crutches Market to Surpass US$ 1.2 Billion by 2027 Amid Rising Prevalence of Osteoporosis and Arthritis Worldwide
43. Canes and Crutches Market to Surpass US$ 1.2 Bn by 2027 Amid Rising Prevalence of Osteoporosis and Arthritis Worldwide
44. Antinuclear Antibody Test Market to Reach $5.0 Bn, Globally, by 2031 at 15.0% CAGR: Allied Market Research
45. Global Rheumatoid Arthritis Diagnosis Tests Market to Reach $766.7 Million by 2026
46. The Global Rheumatoid Arthritis Diagnostic Devices Market is expected to grow by $ 146.54 mn during 2022-2026, accelerating at a CAGR of 5.55% during the forecast period
47. Global Arthritis Monoclonal Antibodies Markets 2022-2031: Focus on Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia
48. Global Wrist Replacement Market to 2030 - Featuring KLS Martin LP, Integra Lifesciences Holdings and Stryker Among Others
49. Intravenous (IV) Ibuprofen Market Expected to Reach $15.48 Million at a CAGR of 13.38% by 2030, Claims AMR
50. Global Wrist Replacement Market to 2030 - Featuring KLS Martin LP, Integra Lifesciences Holdings and Stryker Among Others - ResearchAndMarkets.com
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.